Published February 28, 2024 | Version https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue2,Article228.pdf
Journal article Open

Evaluation of Serum Gamma Glutamyl Transferase Levels in Pre Eclampsia Cases

  • 1. Assistant Professor, Department of Biochemistry, Government Mohan Kumaramangalam Medical College, Steel Plant Road, Salem, Tamil Nadu, India

Description

Background: Preeclampsia is a Pregnancy Specific Syndrome characterised by Hypertension with BP 140/90 mm Hg or more, Proteinuria and edema contributing significantly to Maternal and Foetal Morbidity and Mortality. Endothelial cell dysfunction within the Uteroplacental circulation leads to systemic release of Gamma Glutamyl Transferase (GGT). Aim and Objectives: The main aim of this study is to compare the levels of Serum Gamma Glutamyl Transferase (GGT) levels in pre eclampsia patients and normal pregnancy patients and also to predict the severity of pre eclampsia with GGT. Materials and Method: This case control study was done from November 2017 to January 2018 at Mahatma Gandhi Memorial Government Hospital, Trichy, 30 pre eclampsia patients and 30 normal healthy normotensive pregnant women (controls) were enrolled in the study. All the cases were selected in the third trimester and belongs to the age group 19-35year. Cases with any medical history of hypertension, diabetes, renal disease, liver disease were excluded from the study. Controls were selected from the patients regularly attending the Antenatal clinic (ANC) and Preeclampsia cases were selected from the patients admitted in the ANC ward. The statistical analysis was performed using SPSS version 16. Results and Conclusion: The results were presented as a mean ± SD and p value of less than 0.001 is considered as significant. In our present study, the Serum GGT levels is found to be significantly increased in Pre- eclampsia Patients compared to Normal Pregnant Women with a p value ˂0.001. GGT is also useful in predicting the severity of pre eclampsia.

 

 

Abstract (English)

Background: Preeclampsia is a Pregnancy Specific Syndrome characterised by Hypertension with BP 140/90 mm Hg or more, Proteinuria and edema contributing significantly to Maternal and Foetal Morbidity and Mortality. Endothelial cell dysfunction within the Uteroplacental circulation leads to systemic release of Gamma Glutamyl Transferase (GGT). Aim and Objectives: The main aim of this study is to compare the levels of Serum Gamma Glutamyl Transferase (GGT) levels in pre eclampsia patients and normal pregnancy patients and also to predict the severity of pre eclampsia with GGT. Materials and Method: This case control study was done from November 2017 to January 2018 at Mahatma Gandhi Memorial Government Hospital, Trichy, 30 pre eclampsia patients and 30 normal healthy normotensive pregnant women (controls) were enrolled in the study. All the cases were selected in the third trimester and belongs to the age group 19-35year. Cases with any medical history of hypertension, diabetes, renal disease, liver disease were excluded from the study. Controls were selected from the patients regularly attending the Antenatal clinic (ANC) and Preeclampsia cases were selected from the patients admitted in the ANC ward. The statistical analysis was performed using SPSS version 16. Results and Conclusion: The results were presented as a mean ± SD and p value of less than 0.001 is considered as significant. In our present study, the Serum GGT levels is found to be significantly increased in Pre- eclampsia Patients compared to Normal Pregnant Women with a p value ˂0.001. GGT is also useful in predicting the severity of pre eclampsia.

 

 

Files

IJPCR,Vol16,Issue2,Article228.pdf

Files (721.1 kB)

Name Size Download all
md5:a9386d7e2c3bc27986f5c416cc8454df
721.1 kB Preview Download

Additional details

Dates

Accepted
2024-01-26

References

  • 1. Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutrition reviews. 2013; 71(suppl_1):S18-S25. 2. Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. British MedicalBulletin. 2003; 67(1):161-76. 3. Patil Rr, Choudhari As. Evaluation of Activities of Serum Gamma Glutamyl Transferase And Adenosine Deaminase In Pre-EclampsiaA Case Control Study. Age (In Years).25(4.24):24.96-4.63. 4. Sarkar PD, Sogani S. Evaluation of serum lactate dehydrogenase and gamma glutamyl transferase in preeclamptic pregnancy and its comparison with normal pregnancy in third trimester. 2013. 5. Muti M, Tshimanga M, Notion GT, Bangure D, Chonzi P. Prevalence of pregnancy induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe. BMC cardiovascular disorders. 2015; 15(1):111. 6. Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy: review articles. Cardiovascular journal of Africa. 2016; 27(2):71-8. 7. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium. Circulation. 2011; 123(24):2856-69. 8. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M. Pre-eclampsia: pathophysiology, diagnosis, and management. Vascular health and risk management. 2011; 7:467. 9. Munde S, Hazari N, Thorat A, Gaikwad S, Hatolkar V. Gamma glutamyl transferase and Lactate dehydrogenase as biochemical markers of severity of preeclampsia. platelets. 2014; 5:6. 10. Ilanchezhian T, Priya RS, Suganya S, Rajagopalan B. A study to evaluate the renal function parameters in preclampsia. International Journal of Pharmaceutical Sciences and Research. 2017; 8(1):213. 11. Dacaj R, Izetbegovic S, Stojkanovic G, Dreshaj S. Elevated Liver Enzymes in Cases of Preeclampsia and Intrauterine Growth Restriction. Medical archives. 2016; 70(1):44. 12. Girling J, Dow E, Smith J. Liver function tests in pre‐eclampsia: importance of comparison with a reference range derived for normal pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology. 1997; 104(2):246- 50. 13. Senna A, Abonar E. Early Pregnancy Microalbuminuria as a Predictor of Pre- Eclampsia. JFIV Reprod Med Genet. 2017; 5(196):4-6. 14. Salako BL, Olayemi O, Odukogbe A-TA, Adedapo KS, Aimakhu CO, Alu FE, et al. Microalbuminuria in pregnancy as a predictor of preeclampsia and eclampsia. West African journal of medicine. 2003; 22(4):295-300.